Health
Johnson & Johnson COVID-19 vaccine candidate enters late-stage trials | News – Daily Hive
One shot, instead of two.
Pharma giant Johnson & Johnson has announced its COVID-19 vaccine candidate has entered the late-stage trials.
The pharmaceutical company said about 45,000 participants are currently enrolled in the trials, with interim data expected by the end of January 2021.
If the Johnson & Johnson vaccine candidate proves effective, the company says it will submit an emergency use authorization application to the US Food and Drug Administration (FDA) in February.
Johnson & Johnson’s study, named Ensemble, was…
-
General17 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General23 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
General17 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General17 hours agoWhy the nation needs the Nationals to ditch Net Zero